CELC · Celcuity Inc.
Market Cap
$4.36B
Shares
48.93M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$91.98
Open$89.00
Day$88.64–92.85
52W close$45.22–144.98
Avg vol 30d927K
Short int10.5M · 21.5% float · 13.2d
Short vol61%
Last earningsAug 13, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Oct 13, 2026
Est · unconfirmed
· in 6 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−13%
below
Price vs 50-day avg
−2%
below
RSI (14)
50
neutral
MACD trend
Positive
52-week position
47%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−21%
trailing
YTD return
−8%
this year
Relative strength
−33%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $94 › 200d $106 — 200d above 50d
Institutional flow
Distributing
-0% holders QoQ · +60 funds added
Insider flow
Distributing
Net -$317.8M over 90 days · 100% sells
Short interest
Rising
21.53% of float · ▲ +2.7% MoM · 13.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
279 holders — near 3-yr high, broad support
Squeeze score
83
high risk · 0–100
Fundamentals
EPS growth
−34%
Y/Y
Free cash flow
$-153.5M
Balance sheet
$28.2M
net cash
Quant / Vol
risk profile
Volatility
76%
annualized · 1-yr
Max drawdown
−43%
past year
ATR
5.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−13%
Bearish
Price vs 50-day avg
−2%
Neutral
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
47%
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $94 › 200d $106 — 200d above 50d
Institutional flow
Distributing
-0% holders QoQ · +60 funds added
Insider flow
Distributing
Net -$317.8M over 90 days · 100% sells
Short interest
Rising
21.53% of float · ▲ +2.7% MoM · 13.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
279 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $45
Now $92 · 47%
Range high $145
vs 200-day avg -13%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CELC
this stock
Celcuity Inc.
|
$4.36B | -7.8% | — | — | 21.5% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +20.8% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$84.82B | +6.7% | +20.8% | 20.4 | 2.3% |
|
ARGX
Argenx SE
|
$64.16B | +22.3% | — | — | 1.9% |
|
MRNA
Moderna, Inc.
|
$61.59B | +423.1% | +4.3% | — | 13.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CELC | -0.3% | -0.6% | -20.5% | +3.3% | -7.8% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | +0.2% | +0.7% | -33.2% | +4.0% | -19.5% |
Key facts
CIK
1603454
CUSIP
15102K100
13F (30d)
238 filings
237 filers
Visit website
Investor relations